Evotec SE (EVO) Cash & Current Investments (2009 - 2026)

Evotec SE (EVO) reported Cash & Current Investments of $520704.3 for Q1 2026, up 33.27% on a YoY basis from $390715.1 in Q1 2025, and up 667.39% sequentially from $67853.9 in Q4 2025.

Evotec SE (EVO) Cash & Current Investments (2009 - 2026) Analysis & Trends

Evotec SE (EVO) has 10 years of Cash & Current Investments data on file, last reported at $520704.3 in Q1 2026.

  • For the quarter ending Q1 2026, Cash & Current Investments rose 33.27% year-over-year to $520704.3; the trailing twelve-month figure through Mar 2026 stood at $520704.3 (up 33.27% YoY), and the FY2025 full-year result was $67853.9, down 99.98% from the prior year.
  • Cash & Current Investments grew to $520704.3 in Q1 2026, from $67853.9 in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $465.3 billion in Q1 2024 to a low of $67853.9 in Q4 2025.
  • A 5-year average of $55.5 billion and a median of $947417.2 in 2022 frame the typical range for Cash & Current Investments.
  • Across the five-year window, Cash & Current Investments jumped 7151845.65% in 2022 and plunged 100.0% in 2025, its largest moves.
  • Tracing EVO's Cash & Current Investments over 5 years: stood at $733.0 million in 2022, then retreated by 11.33% to $650.0 million in 2023, then plunged by 48.92% to $332.0 million in 2024, then sank by 99.98% to $67853.9 in 2025, then jumped by 667.39% to $520704.3 in 2026.
  • Business Quant data shows EVO's Cash & Current Investments at $520704.3 in Q1 2026, $67853.9 in Q4 2025, and $277379.4 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 1.86 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 3.74 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 1.94 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 4.06 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 2.15 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 33.59 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.80 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.32 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 428.00 Mn
10 Evotec SE 351.60 Mn 351.08 Mn - 520,704.35

Historic Data

Download Data
DateValue
Mar 31, 2026 520,704.35
Dec 31, 2025 67,853.86
Sep 30, 2025 277,379.36
Jun 30, 2025 393,923.10
Mar 31, 2025 390,715.11
Dec 31, 2024 331.99 Mn
Sep 30, 2024 254.02 Bn
Mar 31, 2024 465.30 Bn
Dec 31, 2023 649.99 Mn
Dec 31, 2022 733.04 Mn
Sep 30, 2022 830,483.30
Jun 30, 2022 947,417.23
Mar 31, 2022 959,392.24
Dec 31, 2021 800.31 Mn
Sep 30, 2021 393.18 Bn
Jun 30, 2021 13.25
Dec 31, 2020 516.60 Mn
Sep 30, 2020 79.43
Dec 31, 2019 306.65 Mn
Sep 30, 2010 24.27 Bn